EA200400603A1 - Новые пептиды - аналоги гормона высвобождения гормона роста человека - Google Patents

Новые пептиды - аналоги гормона высвобождения гормона роста человека

Info

Publication number
EA200400603A1
EA200400603A1 EA200400603A EA200400603A EA200400603A1 EA 200400603 A1 EA200400603 A1 EA 200400603A1 EA 200400603 A EA200400603 A EA 200400603A EA 200400603 A EA200400603 A EA 200400603A EA 200400603 A1 EA200400603 A1 EA 200400603A1
Authority
EA
Eurasian Patent Office
Prior art keywords
guanidine
aminobutyric acid
acid
homoarginine
leu
Prior art date
Application number
EA200400603A
Other languages
English (en)
Other versions
EA007841B1 (ru
Inventor
Ян Издебский
Данута Кунце
Алисия Орловска
Ева Витковска
Веслав Шелеевский
Анджей Кутнер
Кшиштоф Баньковский
Эльзбета Франкиевич
Original Assignee
Институт Фармацеутичний
Заклады Фармаутичне Полфарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Фармацеутичний, Заклады Фармаутичне Полфарма С.А. filed Critical Институт Фармацеутичний
Publication of EA200400603A1 publication Critical patent/EA200400603A1/ru
Publication of EA007841B1 publication Critical patent/EA007841B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Новые пептиды - аналоги гормона высвобождения гормона роста, имеющие последовательность аминокислот формулы Dat-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-R-R-Val-Leu-Ala-Gln-Leu-Ser-Ala-R-R-Leu-Leu-Gln-Asp-Ile-Nle-Asp-R-NH(I), в которой Rпредставляет собой гомоаргинин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой гомоаргинин, орнитин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой гомоаргинин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой гомоаргинин, орнитин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; Rпредставляет собой D-аргинин, гомоаргинин, 4-гуанидин-2-аминомасляную кислоту или 3-гуанидин-2-аминомасляную кислоту; а также их фармацевтически приемлемые соли являются мощными и селективными стимуляторами высвобождения гормона роста и обладают высокой стойкостью к ферментному расщеплению. Новые пептиды получают с использованием способа твердофазного синтеза, включающего: введение подходящих заместителей лизина, 2,4-диаминомасляной кислоты или 2,3-диаминопропионовой кислоты на соответствующие позиции в пептидной цепи, присоединенной к полимерной подложке, снятие защиты с боковых аминогрупп и взаимодействие свободных аминогрупп с гуанидирующим агентом, удаление всех остальных защитных трет-бутилоксикарбонильных групп, а также отделение синтезированного пептида от указанной подложки с последующей его очисткой и необязательное превращение указанного пептида в фармацевтически приемлемую соль.
EA200400603A 2001-10-31 2002-10-30 Новые пептиды - аналоги гормона высвобождения гормона роста человека EA007841B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL350463A PL195917B1 (pl) 2001-10-31 2001-10-31 Nowe peptydy - analogi ludzkiego hormonu uwalniającego hormon wzrostu
PCT/PL2002/000080 WO2003037928A2 (en) 2001-10-31 2002-10-30 Analogs of human growth hormone-releasing hormone, their preparation and use

Publications (2)

Publication Number Publication Date
EA200400603A1 true EA200400603A1 (ru) 2006-06-30
EA007841B1 EA007841B1 (ru) 2007-02-27

Family

ID=20079564

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400603A EA007841B1 (ru) 2001-10-31 2002-10-30 Новые пептиды - аналоги гормона высвобождения гормона роста человека

Country Status (14)

Country Link
US (1) US7928063B2 (ru)
EP (1) EP1442059B1 (ru)
JP (1) JP4401170B2 (ru)
AT (1) ATE353917T1 (ru)
AU (1) AU2002351536A1 (ru)
CA (1) CA2465667C (ru)
DE (1) DE60218199T2 (ru)
EA (1) EA007841B1 (ru)
ES (1) ES2282494T3 (ru)
HU (1) HU229220B1 (ru)
PL (1) PL195917B1 (ru)
SI (1) SI1442059T1 (ru)
UA (1) UA79440C2 (ru)
WO (1) WO2003037928A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05002991A (es) * 2002-09-18 2005-10-05 Univ Montreal Ct Hospitalier Chum Analogos de ghrh.
US8980249B2 (en) 2010-06-03 2015-03-17 University Of Miami Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
US20130261058A1 (en) * 2010-09-16 2013-10-03 University Of Miami Acceleration of wound healing by growth hormone releasing hormone and its agonists
WO2012068187A1 (en) * 2010-11-19 2012-05-24 Merck Sharp & Dohme Corp. Poly(amide) polymers for the delivery of oligonucleotides
JP6342808B2 (ja) * 2011-10-18 2018-06-13 エイルロン セラピューティクス,インコーポレイテッド ペプチドミメティック大環状化合物
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
WO2014100816A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
US9855312B2 (en) 2012-12-21 2018-01-02 University Of Miami GHRH agonists for the treatment of ischemic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416073A (en) * 1983-08-10 1995-05-16 The Adminstrators Of The Tulane Educational Fund Growth hormone-releasing peptides and method of treating animals, therewith
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
US6072075A (en) * 1997-05-22 2000-06-06 The Regents Of The University Of California Guanidinylation reagents

Also Published As

Publication number Publication date
US7928063B2 (en) 2011-04-19
SI1442059T1 (sl) 2007-08-31
HU229220B1 (hu) 2013-09-30
PL350463A1 (en) 2003-05-05
UA79440C2 (ru) 2007-06-25
WO2003037928A3 (en) 2004-03-04
HUP0401589A3 (en) 2005-11-28
ATE353917T1 (de) 2007-03-15
US20060172927A1 (en) 2006-08-03
EP1442059B1 (en) 2007-02-14
JP2005517633A (ja) 2005-06-16
WO2003037928A2 (en) 2003-05-08
HUP0401589A2 (hu) 2004-11-29
ES2282494T3 (es) 2007-10-16
CA2465667A1 (en) 2003-05-08
DE60218199D1 (de) 2007-03-29
PL195917B1 (pl) 2007-11-30
AU2002351536A1 (en) 2003-05-12
EA007841B1 (ru) 2007-02-27
DE60218199T2 (de) 2007-11-22
EP1442059A2 (en) 2004-08-04
JP4401170B2 (ja) 2010-01-20
CA2465667C (en) 2011-03-08

Similar Documents

Publication Publication Date Title
ES2957399T3 (es) Método de síntesis de péptidos
FI120691B (fi) Ei-terapeuttinen menetelmä kasvuhormonin vapautumisen edistämiseksi eläimessä
US5700827A (en) Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds
AU646767B2 (en) Antithrombotic agents
KR101904808B1 (ko) 데가렐릭스 및 이의 중간 화합물의 제조 방법
KR910006324A (ko) 펩티다아제 및 아이소머라제 억제제
US8492345B2 (en) Cyclic peptide antitumor agents
EP0042291B1 (en) Methods and compositions for preparation of h-arg-x-z-y-tyr-r
AU673431B2 (en) Motilin-like polypeptides that inhibit gastrointestinal motor activity
EP0082568B1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
EA200400603A1 (ru) Новые пептиды - аналоги гормона высвобождения гормона роста человека
EP0401177B1 (en) Synthetic peptide antagonists of neurokinin a, salts thereof and respective preparation processes
JP2949129B2 (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
HU186375B (en) Process for the preparation of biologically active encephalina derivatives
JPH08505611A (ja) 5位及び6位に修飾アミノアシル残基を有するlhrh拮抗薬
HU185230B (en) Process for producing pharmacologically active encephaline analogous peptides
NZ253452A (en) Platelet aggregation inhibitors which are peptide analogues, composition.
AU718320B2 (en) Peptide derivatives
RU2006106721A (ru) Получение пептидов соматостатина
ES2203934T3 (es) Compuestos monociclicos con cuatro restos bifuncionales que tienen accon antagonista en nk-2.
AU718192B2 (en) Peptide derivatives
AU640534B2 (en) Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof
CA2118253A1 (en) Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
CA1284550C (en) Retro-inverso analogs of the bradykinin potentiating peptide bpp*in5a*xx
GB992957A (en) New decapeptides and their manufacture

Legal Events

Date Code Title Description
NF4A Restoration of lapsed right to a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM BY KZ MD TJ RU

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU